Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 0 · FY2023 0 · FY2024 0
Operates in Healthcare Services — In-patient & out-patient services. Per the activity note to the FY2024 annual report, the company provides medical services. Founded on 16 March 2000; wholly owned by Aversi-Pharma.
Subsidiary of Aversi-Pharma (100.0%)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| 13,419 | 18,074 | 22,356 | 23,884 | 42,769 | 36,501 | 40,641 | 34,606 | +14.5% | |
| 47,609 | 46,383 | 53,140 | 55,995 | 58,277 | 77,641 | 88,912 | 120,694 | +14.2% | |
| TOTAL ASSETS | 61,028 | 64,457 | 75,496 | 79,879 | 101,046 | 114,143 | 129,553 | 155,300 | +14.3% |
| 9,609 | 4,728 | 7,520 | 6,734 | 12,773 | 10,304 | 14,254 | 18,284 | +9.6% | |
| 0 | 0 | 1,175 | 990 | 815 | 582 | 2,766 | 6,718 | +41.7% | |
| TOTAL LIABILITIES | 9,609 | 4,728 | 8,695 | 7,724 | 13,588 | 10,886 | 17,021 | 25,001 | +14.6% |
| 51,419 | 59,729 | 66,801 | 72,155 | 87,458 | 103,257 | 112,532 | 130,299 | +14.2% | |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | |||||||||
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cash & Equivalents | 1,258 | 4,093 | 2,935 | 5,649 | 1,863 | 12,922 | 19,951 | 13,743 | +40.7% |
| Net Debt | 1,258 | 4,093 | 2,935 | 5,649 | 1,863 | 12,922 | 19,951 | 13,743 | +40.7% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →